Abstract
Objective:
Strategies to reduce Retinopathy of Prematurity (ROP) have focused primarily on respiratory management. Hyperglycemia (HG) and insulin use, risk factors for adult diabetic retinopathy, as well as growth rates may be modifiable variables useful to reduce ROP.
Study Design:
This was a retrospective chart review of all infants born at <30 weeks gestation from 2003 to 2007 who survived to discharge in our neonatal intensive care unit (NICU). All whole-blood glucose values (BG in mg dl−1) done in the first 29 days of life were collected for analysis.
Result:
BGs were done at least every 3 to 6 h for the first 48 to 96 h of life, then every 6 to 24 h thereafter, as long as infants remained on hyperalimentation. Hyperglycemia was defined as mild (BG 151 to 180), moderate (181 to 210) or severe (>210). Insulin use (given if BG>180 to 210) was also noted for each simultaneous BG. ROP was classified as none, mild (stage 1 to 2) or severe (stage 3 to 4). Growth velocity (g kg−1 per day), length and head circumference were also analyzed. In all, 372 infants mean (s.d.) gestational age 27.6 (1.4) weeks, mean (s.d.) birth weight 994 (242) g had 18 649 BGs analyzed. 103 (28%) of the infants had mild ROP and 29 (8%) had severe ROP. 137 (37%) of the infants received at least 1 day of exogenous insulin (median days 9, range 1 to 26). Higher cumulative mean BG, more episodes of HG, and more insulin exposure were associated with an increased incidence and severity of ROP. Ordinal logistic regression identified lower gestational age, male gender, fetal growth restriction, slower NICU growth velocity, and higher BG as predictors for severity of ROP. However, insulin use was a stronger predictor than BG, and replaced it in the risk model.
Conclusion:
After adjusting for important risk factors, HG and especially insulin use in premature infants may increase the risk of ROP. In addition, slower NICU growth velocity, but not rates of head or length growth, was predictive of ROP.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$259.00 per year
only $21.58 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Mantagos IS, Vanderveen DK, Smith LEH . Emerging treatments for retinopathy of prematurity. Sem Ophthalmology 2009; 24: 82–86.
Gargus RA, Vohr BR, Tyson JE, High P, Higgins RD, Wrage LA et al. Unimpaired outcomes for extremely low birth weight infants at 18 to 22 months. Pediatrics 2009; 124: 112–121.
Chow LC, Wright KW, Sola A . Can changes in clinical practice decrease the incidence of severe retinopathy of prematurity in very low birth weight infants? Pediatrics 2003; 111: 339–345.
Brion LP, Bell EF, Raghuveer TS . Vitamin E supplementation for prevention of morbidity and mortality in preterm infants. Cochrane Database Syst Rev 2009; 3): CD003665.
Vermont Oxford Network Annual Report 2008, Vermont Oxford Network, Burlington VT Section 1, Table 1.2..
Ziegler EE, Thureen PJ, Carlson SJ . Aggressive nutrition of the very low birthweight infant. Clin Perinatology 2002; 29: 225–244.
Garg R, Agthe AG, Donohue PK, Lehmann CU . Hyperglycemia and retinopathy of prematurity in very low birth weight infants. J Perinatology 2003; 23: 186–194.
Ertl T, Gyarmati J, Gaal V, Szabo I . Relationship between hyperglycemia and retinopathy of prematurity in very low birth weight infants. Biol Neonate 2006; 89: 56–59.
Blanco CL, Baillargeon JG, Morrison RL, Gong AK . Hyperglycemia in extremely low birth weight infants in a predominantly Hispanic population and related morbidities. J Perinatology 2006; 26: 737–741.
Hellstrom A, Hard AL, Engstrom E, Niklasson A, Andersson E, Smith L et al. Early weight gain predicts retinopathy in preterm infants: new, simple, efficient approach to screening. Pediatrics 2009; 123: e638–e645.
International Committee for the Classification of Retinopathy of Prematurity. The international classification of retinopathy of prematurity revisited. Arch Ophthalmology 2005; 123: 991–999.
Patel AL, Engstrom JL, Meier PP, Kimura RE . Accuracy of methods for calculating postnatal growth velocity for extremely low birth weight infants. Pediatrics 2005; 116: 1466–1473.
Hosmer DW, Lemeshow S . Applied Logistic Regression. John Wiley & Sons: New York, NY, 2000 2nd Edn.
Vermont Oxford Network Annual Report, 2008. Vermont Oxford Network, Burlington, VT. Section 1 1 Figure 1.17 1.17, Center 139.
Hylander MA, Strobino DM, Pezzullo JC, Dhanireddy R . Association of human milk feedings with a reduction in retinopathy of prematurity among very low birthweight infants. J Perinatology 2001; 21: 356–362.
Haroon Parupia MF, Dhanireddy R . Association of postnatal dexamethasone use and fungal sepsis in the development of severe retinopathy of prematurity and progression to laser therapy in extremely low-birth-weight infants. J Perinatology 2001; 21: 242–247.
Suk KK, Dunbar JA, Liu A, Daher NS, Leng CK, Leng JK et al. Human recombinant erythropoietin and the incidence of retinopathy of prematurity: a multiple regression model. J AAPOS 2008; 12: 233–238.
Wong TY, Klein R, Amirul Islam FM, Cotch MF, Folsom AR, Klein BE et al. Diabetic retinopathy in a multi-ethnic cohort in the United States. Am J Ophthalmology 2006; 141: 446–455.
Hellstrom A, Engstrom E, Hard AL, Albertsson-Wikland K, Carlsson B, Niklasson A et al. Postnatal serum insulin-like growth factor 1 deficiency is associated with retinopathy of prematurity and other complications of premature birth. Pediatrics 2003; 112: 1016–1020.
Hellstrom A, Perruzzi C, Ju M, Engstrom E, Hard AL, Liu JL et al. Low IGF-1 suppresses VEGF survival signaling in retinal endothelial cells: direct correlation with clinical retinopathy of prematurity. Proc Natl Acad Sci USA 2001; 98: 5804–5808.
Smith LE, Shen W, Perruzzi C, Soker S, Kinose F, Xu X et al. Regulation of vascular endothelial growth factor-dependent retinal neovascularization by insulin-like growth factor-1 receptor. Nat Med 1999; 5: 1390–1395.
Beardsall K, Ogilvy-Stuart AL, Frystyk J, Chen JW, Thompson M, Ahluwalia J et al. Early elective insulin therapy can reduce hyperglycemia and increase insulin-like growth factor-1 in very low birth weight infants. J Pediatrics 2007; 151: 611–617.
Beardsall K, Vanhaesebrouck S, Ogilvy-Stuart AL, Vanhole C, Palmer CR, van Weissenbruch M et al. Early insulin therapy in very-low-birth-weight infants. N Engl J Med 2008; 359: 1873–1884.
Allegaert K, Vanhole C, Casteels I, Naulaers G, Debeer A, Cossey V et al. Perinatal growth characteristics and associated risk of developing threshold retinopathy of prematurity. J AAPOS 2003; 7: 34–37.
Lofqvist C, Hansen-Pupp I, Andersson E, Holm K, Smith LE, Ley D et al. Validation of a new retinopathy of prematurity screening method monitoring longitudinal postnatal weight and insulinlike growth factor 1. Arch Ophthal 2009; 127: 622–627.
Lofqvist C, Engstrom E, Sigurdsson F, Hard AL, Niklasson A, Ewald U et al. Postnatal head growth deficit among premature infants parallels retinopathy of prematurity and insulin-like growth factor-1 deficit. Pediatrics 2006; 117: 1930–1938.
Poulaki V, Qin W, Joussen AM, Hurlbut P, Wiegand SJ, Rudge J et al. Acute intensive insulin therapy exacerbates diabetic blood-retinal barrier breakdown via hypoxia-inducible factor-1a and VEGF. J Clin Invest 2002; 109: 805–815.
Acknowledgements
We thank Erin Giltner and Nicole Tipping for their expert assistance collecting and organizing the patient data used in this investigation. We thank the Vollum Foundation at PSVMC for their generous support of this study. This investigation was supported by a grant from the Vollum Foundation.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Competing interests
The authors declare no conflict of interest.
Rights and permissions
About this article
Cite this article
Kaempf, J., Kaempf, A., Wu, Y. et al. Hyperglycemia, insulin and slower growth velocity may increase the risk of retinopathy of prematurity. J Perinatol 31, 251–257 (2011). https://doi.org/10.1038/jp.2010.152
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/jp.2010.152
Keywords
This article is cited by
-
Hyperglycemia and prematurity: a narrative review
Pediatric Research (2023)
-
FGF21 via mitochondrial lipid oxidation promotes physiological vascularization in a mouse model of Phase I ROP
Angiogenesis (2023)
-
The association of various obstetric and perinatal factors with retinopathy of prematurity
International Ophthalmology (2022)
-
Correlation between hyperglycemia and glycated albumin with retinopathy of prematurity
Scientific Reports (2021)
-
80 Years of vision: preventing blindness from retinopathy of prematurity
Journal of Perinatology (2021)